Effect of intra-BLA administration of CB1 cannabinoid receptor agonist on sensitization to antinociceptive effect of morphine and expression of μ-opioid receptor in the nucleus accumbens

被引：0
|
作者：
Pirasteh, A. [1 ]
Molaee, M. [1 ]
Haghparast, A. [1 ]
机构：
[1] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran
来源：
JOURNAL OF PAIN | 2015年 / 16卷 / 04期
关键词：
D O I：
10.1016/j.jpain.2015.01.206
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
288
引用
收藏
页码：S48 / S48
页数：1
相关论文
共 50 条
  • [41] Effects of repeated administration with CP-55,940, a cannabinoid CB1 receptor agonist on the metabolism of the hepatic heme
    Fontanellas, A
    Manzanares, J
    García-Bravo, M
    Buzaleh, AM
    Méndez, M
    Oliva, JM
    Batlle, A
    Palomo, T
    de Salamanca, RE
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (08): : 1620 - 1625
  • [42] Capsazepine, a Transient Receptor Potential Vanilloid Type 1 (TRPV1) Antagonist, Attenuates Antinociceptive Effect of CB1 Receptor agonist, WIN55,212-2, in the Rat Nucleus Cuneiformis
    Parvishan, Asghar
    Taslimi, Zahra
    Ebrahimzadeh, Mohammad
    Haghparast, Abbas
    BASIC AND CLINICAL NEUROSCIENCE, 2011, 2 (04) : 19 - 26
  • [43] Cannabinoid CB1 receptor blockade enhances the protective effect of melanocortins in hemorrhagic shock in the rat
    Cainazzo, MM
    Ferrazza, G
    Mioni, C
    Bazzani, C
    Bertolini, A
    Guarini, S
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 441 (1-2) : 91 - 97
  • [44] Effect of the cannabinoid CB1 receptor antagonist SR 141716 in a rat model of liver inflammation
    Caraceni, P
    Pertosa, AM
    Domenicali, M
    Cavalieri, B
    Perrelli, MG
    Principe, A
    Cutrin, JC
    Croci, T
    Bernardi, M
    HEPATOLOGY, 2004, 40 (04) : 698A - 698A
  • [45] Effect of Cannabinoid CB1 Receptor Ligands on Body Weight and Bone Mass in Mice.
    Park, S.
    Hwang, C.
    Choi, S.
    Kwak, H.
    Jeong, M.
    Kang, Y.
    Yim, C.
    Yoon, H.
    Han, K.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S459 - S459
  • [46] Negative allosteric modulation of CB1 cannabinoid receptor signalling decreases intravenous morphine self-administration and relapse in mice
    Oliva, Idaira
    Kazi, Fezaan
    Cantwell, Lucas N.
    Thakur, Ganesh A.
    Crystal, Jonathon D.
    Hohmann, Andrea G.
    ADDICTION BIOLOGY, 2024, 29 (08)
  • [47] The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: Evidence from postmortem human brain
    Erdozain, A. M.
    Diez-Alarcia, R.
    Meana, J. J.
    Callado, L. F.
    BIOCHEMICAL PHARMACOLOGY, 2012, 83 (02) : 260 - 268
  • [48] Hallucinatory and rewarding effect of salvinorin A in zebrafish:: κ-opioid and CB1-cannabinoid receptor involvement
    Braida, Daniela
    Limonta, Valeria
    Pegorini, Simona
    Zani, Alessia
    Guerini-Rocco, Chiara
    Gori, Enzo
    Sala, Mariaelvina
    PSYCHOPHARMACOLOGY, 2007, 190 (04) : 441 - 448
  • [49] Hallucinatory and rewarding effect of salvinorin A in zebrafish: κ-opioid and CB1-cannabinoid receptor involvement
    Daniela Braida
    Valeria Limonta
    Simona Pegorini
    Alessia Zani
    Chiara Guerini-Rocco
    Enzo Gori
    Mariaelvina Sala
    Psychopharmacology, 2007, 190 : 441 - 448
  • [50] Involvement of nitric oxide in the gastroprotective effect of ACEA, a selective cannabinoid CB1 receptor agonist, on aspirin-induced gastric ulceration
    Rutkowska, M.
    Fereniec-Golebiewska, L.
    PHARMAZIE, 2009, 64 (09): : 595 - 597
12345